DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Reset all filters
01 2Dr. Reddy's Laboratories
02 1NanoAlvand
03 3Ever Pharma
04 2medac
05 3Advanz Pharma
06 2Baxter Healthcare Corporation
07 4Bayer AG
08 2Chia Tai Tianqing Pharmaceutical Group
09 11Eisai
10 4Eisai Inc
11 1Ever Valinject Gmbh
12 1GLAND PHARMA LIMITED
13 2GSK
14 3Glenmark Pharmaceuticals
15 1Hikma Pharmaceuticals
16 1JIANGXI KVVIT PHARM
17 1Long Grove Pharmaceuticals
18 1Natco Pharma (Canada) Inc
19 5STADA Arzneimittel
20 1Sandoz B2B
21 2Viatris
22 3Yes Pharmaceutical Development Services Gmbh
23 3Zentiva
Reset all filters
01 1Eribulina 0.88Mg 2Ml 1 Units Parenteral Use
02 1INJ
03 1Injectable
04 22Injectable Solution
05 9Injection Solution
06 2SOLUTION
07 9SOLUTION;INTRAVENOUS
08 8Solution For Injection
09 1Solution for Injection
10 1Solution for injection
11 4Blank
Reset all filters
01 1Allowed
02 10Approved
03 10Authorized
04 1Cancelled
05 4Marketed
06 1Originator
07 15Prescription
08 9RX
09 8Blank
Reset all filters
01 8ERIBULIN MESYLATE
02 2Eribulin
03 3Eribulin Advanz Pharma
04 5Eribulin Baxter
05 1Eribulin Ever Pharma
06 2Eribulin Glenmark
07 1Eribulin Medac
08 3Eribulin Stada
09 1Eribulin Stada Arzneimittel Ag
10 1Eribulin Zentiva
11 1Eribulin "Ever Pharma"
12 1Eribulin "Glenmark"
13 1Eribulin "Medac"
14 1Eribulin "Stada"
15 1Eribulin "Viatris"
16 1Eribulin "Zentiva"
17 1Eribulina Cttq
18 1Eribulina Ever Pharma
19 1Eribulina Glenmark
20 1Eribulina Hikma
21 1Eribulina Viatris
22 1Eribulina Zentiva
23 2HALAVEN
24 1Halave
25 12Halaven
26 3Mevlyq
27 1NAT-ERIBULIN
28 1Nibulin®
Reset all filters
01 4Australia
02 1Austria
03 2Canada
04 9Denmark
05 4Estonia
06 1India
07 1Iran
08 1Italy
09 4Norway
10 1South Africa
11 11Spain
12 10Sweden
13 1Switzerland
14 9USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2025-07-03
Application Number : 217473
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Iran
Brand Name : Nibulin®
Dosage Form : Solution for Injection
Dosage Strength : 1MG/2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eribulin Ever Pharma
Dosage Form : Injectable Solution
Dosage Strength : 0.44mg/ml
Packaging :
Approval Date : 07/06/2024
Application Number : 20221221000240
Regulatory Info : Approved
Registration Country : Sweden
medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eribulin Medac
Dosage Form : Injectable Solution
Dosage Strength : 0.44mg/ml
Packaging :
Approval Date : 30/11/2023
Application Number : 20220930000183
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Eribulin
Dosage Form : Injectable
Dosage Strength : 0.5 mg/ml (2 ml)
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Regulatory Info :
Registration Country : Austria
Brand Name : Eribulin
Dosage Form : Solution for injection
Dosage Strength : 0.44MG/1ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Austria
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Eribulina Ever Pharma
Dosage Form : Injectable Solution
Dosage Strength : 0.44MG
Packaging :
Approval Date : 30-09-2024
Application Number : 89838
Regulatory Info : Authorized
Registration Country : Spain
medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Eribulin \"Medac\"
Dosage Form : Injection Solution
Dosage Strength : 0.44mg/ml
Packaging :
Approval Date : 24-06-2024
Application Number : 28106846122
Regulatory Info : Prescription
Registration Country : Denmark
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eribulin Advanz Pharma
Dosage Form : Injectable Solution
Dosage Strength : 0.44mg/ml
Packaging :
Approval Date : 06/09/2023
Application Number : 20220812000027
Regulatory Info : Approved
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-10-01
Application Number : 217250
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eribulin Baxter
Dosage Form : Injectable Solution
Dosage Strength : 0.44mg/ml
Packaging :
Approval Date : 27/06/2024
Application Number : 20230427000060
Regulatory Info : Approved
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2025-03-04
Application Number : 218743
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Brand Name : HALAVEN
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2010-11-15
Application Number : 201532
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Italy
Brand Name : Halaven
Dosage Form : Eribulina 0.88Mg 2Ml 1 Units Parenteral Use
Dosage Strength : 1 vial EV 0.88 mg 2 ml 0.44 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-04-05
Application Number : 218047
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2025-08-05
Application Number : 218142
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eribulin Glenmark
Dosage Form : Injectable Solution
Dosage Strength : 0.44mg/ml
Packaging :
Approval Date : 30/11/2023
Application Number : 20220930000152
Regulatory Info : Approved
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-07-18
Application Number : 214850
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2025-06-09
Application Number : 214310
Regulatory Info : RX
Registration Country : USA

Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-06-28
Application Number : 218281
Regulatory Info : RX
Registration Country : USA

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF